Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278339 | 0.88 | KDM4E (0.38) | HDAC1KDM4ECA2PTGS1MMP12 | |
| SCHEMBL20504550 | 0.88 | KDM4E (0.38) | HDAC1KDM4ECA2PTGS1MMP12 | |
| SCHEMBL27905560 | 0.87 | CCR2 (0.40) | HDAC8HDAC6HDAC3HDAC1HDAC2 | |
| SCHEMBL28690185 | 0.82 | CCR2 (0.33) | CCR2GRIK1GRIK2ALDH1A1 | |
| SCHEMBL2350820 | 0.81 | — | — | |
| SCHEMBL340695 | 0.80 | CTSD (0.38) | KDM4ECA2CCR2GRIK1GRIK2 | |
| SCHEMBL3286598 | 0.78 | CCR2 (0.31) | KDM4ECCR2GRIK1GRIK2 | |
| SCHEMBL26650993 | 0.78 | CCR2 (0.34) | CCR2GRIK1GRIK2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8900383 | 0.78 | CTSD (0.37) | KDM4ECCR2GRIK1GRIK2ALDH1A1 | |
| SCHEMBL565768 | 0.77 | KDM7A (0.32) | CCR2GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113908289-B | Antitumor multi-element drug-carrying system with precisely regulated and controlled drug proportion and preparation method thereof | 北京化工大学 | 2023-07-25 | — | — | CN | claimed |
| CN-114621393-A | Copolymer of N- (2-hydroxy) propyl methacrylamide and N-methacryloyl glycyl glycine and application thereof | 华侨大学 | 2022-06-14 | — | — | CN | claimed |
| CN-113908289-A | Anti-tumor multi-element drug loading system with accurately regulated drug proportion and preparation method thereof | 北京化工大学 | 2022-01-11 | — | — | CN | claimed |
| CN-112604003-B | Anti-tumor composition based on nano-silver material and application thereof | 湖南航天天麓新材料检测有限责任公司 | 2021-08-20 | — | — | CN | claimed |
| CN-110613734-B | Polymer/silver activity bonding substance for inhibiting proliferation of activated macrophages, and preparation and application thereof | 中南大学 | 2020-06-16 | — | — | CN | claimed |
| CN-110613734-A | Polymer/silver activity bonding substance for inhibiting proliferation of activated macrophages, and preparation and application thereof | 中南大学 | 2019-12-27 | — | — | CN | claimed |
| CN-103936945-B | Efficient anti-tumor targeting drug carrier and preparation method thereof | 中国科学院化学研究所 | 2017-02-08 | — | — | CN | claimed |
| CN-102803228-B | The unstable triggers unit of acid | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2015-11-25 | — | — | CN | claimed |
| EP-1763364-A2 | METHODS AND COMPOSITIONS COMPRISING SUPRAMOLECULAR CONSTRUCTS | AC Immune S.A. (CH) | 2007-03-21 | — | — | EP | claimed |
| WO-2005081872-A2 | METHODS AND COMPOSITIONS COMPRISING SUPRAMOLECULAR CONSTRUCTS | AC IMMUNE SA (CH) | 2005-09-09 | — | — | WO | claimed |
| WO-1992019288-A1 | CATHETER HAVING A COATING ON THE EXPOSED SURFACE THEREOF | PHARMA-PLAST INTERNATIONAL A/S (DK) | 1992-11-12 | — | — | WO | claimed |
| EP-2632434-B1 | LIPOSOME-BASED CONSTRUCT COMPRISING A PEPTIDE MODIFIED THROUGH HYDROPHOBIC MOIETIES | AC IMMUNE SA (CH) | 2025-08-20 | — | — | EP | disclosed |
| US-20240270829-A1 | Vaccine Therapy | AC IMMUNE SA (CH) | 2024-08-15 | — | — | US | disclosed |
| CN-113908289-B | Antitumor multi-element drug-carrying system with precisely regulated and controlled drug proportion and preparation method thereof | 北京化工大学 | 2023-07-25 | — | — | CN | disclosed |
| CN-113908289-B | Antitumor multi-element drug-carrying system with precisely regulated and controlled drug proportion and preparation method thereof | 北京化工大学 | 2023-07-25 | — | — | CN | disclosed |
| WO-2007068411-A2 | THERAPEUTIC VACCINE | AC IMMUNE S.A. (CH) | 2007-06-21 | — | — | WO | disclosed |
| EP-1763364-A2 | METHODS AND COMPOSITIONS COMPRISING SUPRAMOLECULAR CONSTRUCTS | AC Immune S.A. (CH) | 2007-03-21 | — | — | EP | disclosed |
| US-20060233758-A1 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | AC IMMUNE SA (CH) | 2006-10-19 | — | — | US | disclosed |
| US-20050255561-A1 | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers | AC IMMUNE SA (CH) | 2005-11-17 | — | — | US | disclosed |
| WO-2005081872-A2 | METHODS AND COMPOSITIONS COMPRISING SUPRAMOLECULAR CONSTRUCTS | AC IMMUNE SA (CH) | 2005-09-09 | — | — | WO | disclosed |